59 related articles for article (PubMed ID: 9258534)
1. Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and D.
Franzot SP; Fries BC; Cleare W; Casadevall A
J Clin Microbiol; 1998 Aug; 36(8):2200-4. PubMed ID: 9665991
[TBL] [Abstract][Full Text] [Related]
2. Isolation of Cryptococcus gattii from a Castanopsis argyrophylla tree hollow (Mai-Kaw), Chiang Mai, Thailand.
Khayhan K; Hagen F; Norkaew T; Puengchan T; Boekhout T; Sriburee P
Mycopathologia; 2017 Apr; 182(3-4):365-370. PubMed ID: 28265797
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.
Lizarazo J; Escandón P; Agudelo CI; Firacative C; Meyer W; Castañeda E
PLoS Negl Trop Dis; 2014; 8(11):e3272. PubMed ID: 25411779
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor STE12alpha has distinct roles in morphogenesis, virulence, and ecological fitness of the primary pathogenic yeast Cryptococcus gattii.
Ren P; Springer DJ; Behr MJ; Samsonoff WA; Chaturvedi S; Chaturvedi V
Eukaryot Cell; 2006 Jul; 5(7):1065-80. PubMed ID: 16835451
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcus gattii in AIDS patients, southern California.
Chaturvedi S; Dyavaiah M; Larsen RA; Chaturvedi V
Emerg Infect Dis; 2005 Nov; 11(11):1686-92. PubMed ID: 16318719
[TBL] [Abstract][Full Text] [Related]
7. The isolation, characterization and antifungal susceptibilities of Cryptococcus neoformans from bird excreta in Klang Valley, Malaysia.
Tay ST; Chai HC; Na SL; Hamimah H; Rohani MY; Soo-Hoo TS
Mycopathologia; 2005 Jun; 159(4):509-13. PubMed ID: 15983736
[TBL] [Abstract][Full Text] [Related]
8. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Doern GV; Diekema DJ
J Clin Microbiol; 2005 May; 43(5):2163-7. PubMed ID: 15872236
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
Chandenier J; Adou-Bryn KD; Douchet C; Sar B; Kombila M; Swinne D; Thérizol-Ferly M; Buisson Y; Richard-Lenoble D
Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):506-8. PubMed ID: 15141336
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.
Steenbergen JN; Casadevall A
J Clin Microbiol; 2000 May; 38(5):1974-6. PubMed ID: 10790132
[TBL] [Abstract][Full Text] [Related]
11. The ins and outs of DNA fingerprinting the infectious fungi.
Soll DR
Clin Microbiol Rev; 2000 Apr; 13(2):332-70. PubMed ID: 10756003
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcosis in AIDS.
Imwidthaya P; Poungvarin N
Postgrad Med J; 2000 Feb; 76(892):85-8. PubMed ID: 10644384
[TBL] [Abstract][Full Text] [Related]
13. Identification and genetic homogeneity of Trichophyton tonsurans isolated from several regions by random amplified polymorphic DNA.
Kim JA; Takizawa K; Fukushima K; Nishimura K; Miyaji M
Mycopathologia; 1999; 145(1):1-6. PubMed ID: 10560622
[TBL] [Abstract][Full Text] [Related]
14. New PCR primer pairs specific for Cryptococcus neoformans serotype A or B prepared on the basis of random amplified polymorphic DNA fingerprint pattern analyses.
Aoki FH; Imai T; Tanaka R; Mikami Y; Taguchi H; Nishimura NF; Nishimura K; Miyaji M; Schreiber AZ; Branchini ML
J Clin Microbiol; 1999 Feb; 37(2):315-20. PubMed ID: 9889210
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of Histoplasma capsulatum strains isolated from clinical specimens in thailand by a PCR-based random amplified polymorphic DNA method.
Poonwan N; Imai T; Mekha N; Yazawa K; Mikami Y; Ando A; Nagata Y
J Clin Microbiol; 1998 Oct; 36(10):3073-6. PubMed ID: 9738073
[TBL] [Abstract][Full Text] [Related]
16. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.
Poonwan N; Mikami Y; Poosuwan S; Boon-Long J; Mekha N; Kusum M; Yazawa K; Tanaka R; Nishimura K; Konyama K
Eur J Epidemiol; 1997 Apr; 13(3):335-40. PubMed ID: 9258534
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil.
de F L Fernandes O; Passos XS; Souza LK; Miranda AT; Cerqueira CH; Silva Mdo R
Mem Inst Oswaldo Cruz; 2003 Sep; 98(6):839-41. PubMed ID: 14595465
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
